Beijing Tide Pharmaceutical: Loxoprofen Sodium Gel Patch approved for market launch, achieving a full pipeline layout in the pain relief field
SINO BIOPHARM's subsidiary Beijing Tide Pharmaceutical announced that its developed Loxoprofen Sodium Gel Patch has recently been approved for marketing by the National Medical Products Administration of China, indicated for the treatment of osteoarthritis, muscle pain, and inflammation and pain relief caused by trauma
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments